We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Scientists Retraining Coronavirus-Specific T Cells to Target Cancer Cells in Novel Immune-Oncology Approach

By HospiMedica International staff writers
Posted on 16 Sep 2020
Illustration
Illustration
An international team of scientists are examining whether the immune response to SARS-CoV-2 could be repurposed as the next generation of cancer immunotherapy.

The immune system helps protect against viruses, bacteria and anything harmful, but does not protect against cancer because it fails to recognize cancer as a threat. Dr. Shashi Gujar, a scientist with the Department of Pathology at Dalhousie University (Halifax, Nova Scotia, Canada), along with partners in France, Demark, Germany, the US and India, believes that this is where viruses like COVID-19-causing coronavirus can play a key role.

When a person becomes infected with SARS-CoV-2 coronavirus, their immune system recognizes the virus and activates a particular type of immune cells called “T cells.” These T cells act in a highly precise manner and kill only virus-harbouring cells. Multiple vaccines being tested internationally have shown a similar capacity to activate these coronavirus-specific T-cells. These T cells can establish a memory response that maintains active protection against possible re-infection with the virus, which means that coronavirus-specific T cells can hunt for the virus inside the body, eliminate the areas where the virus replicates, and aid in the recovery from COVID-19.

Dr. Gujar and his team are trying to get these same T cells to go after tumors by getting the cancer cells to express the same identifying tags as the coronavirus-infected cells, and become the targets of the anti-coronavirus T cells. Dr. Gujar and his international collaborators are currently in the process of testing the coronavirus-specific tags (called as epitopes in scientific terms) that exist in different human populations. From there, they will prepare a cocktail of these tags that can be used in human clinics to cure cancers. According to Dr. Gujar, what makes this research truly unique is that due to infection or vaccination, the coronavirus-specific cells have the potential to be found in millions of individuals worldwide- making the use of this cancer immunotherapy useful for masses globally.

“We’ve figured out how to trick your coronavirus-specific T cells to think that your cancer is infected by the virus,” said Dr. Gujar. “The key is to do this without using the virus or actually causing the real infection.”

“Once we know it works, this immunotherapy will actually be a straightforward process, and may be something we’ll be able to start using on patients sooner rather than later. This is a highly novel and practical strategy to harness virus-specific T cells against various types of cancers. That’s what makes it so exciting,” added Dr. Gujar.

Related Links:
Dalhousie University

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
MR Trolley
MR9002
New
Short Phlebotomy Cart
MSWA-3469-WHT

Channels

Critical Care

view channel
Image: The skin-like sensor monitors internal and external body movement, and electrical signals (Photo courtesy of Huanyu “Larry” Cheng and Jennifer M. McCann)

Skin-Like Sensor Monitors Vital Signs and Tracks Healing After Surgery

Medical conditions such as bladder control issues and the need for monitoring vital signs after surgery require precise, long-term tracking to improve patient outcomes. These conditions can be challenging... Read more

Surgical Techniques

view channel
Image: For the first time, a fluorescent-guided nerve imaging agent has shown promise for use in humans (Photo courtesy of VUMC)

Fluorescent Imaging Agent ‘Lights Up’ Nerves for Better Visualization During Surgery

Surgical nerve injury is a significant concern in head and neck surgeries, where nerves are at risk of being inadvertently damaged during procedures. Such injuries can lead to complications that may impact... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more